Page 440 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

414 Index

pressure sore, 216 Q
prevalence rate, 67, 348
prevention, 62, 66, 99, 169, 170, 174, 216, 360, 361 quality of life, 19, 321, 332
primary systemic vasculitis, ix, 24, 66, 71, 76, 77, quantification, 96, 159, 332
questionnaire, 82
81, 83, 146, 162, 199, 219, 271, 273, 311, 337,
361 R
priming, 182, 184, 188, 193, 195
principles, 45 race, 262
probability, 149, 153, 156, 158, 270, 281, 317, 325, radiation, 281, 320
341 RANTES, 98, 110
probe, 31 rapidly progressive glomerulonephritis, 22, 162, 250,
prodrome, 143, 385
professionals, 82, 152 266, 268
progenitor cells, 195 rash, 8, 23, 25, 30, 38, 49, 162, 164, 165, 181, 214,
pro-inflammatory, 165, 264, 314
project, 123 286, 287, 301, 345, 352
proliferation, 9, 19, 21, 23, 30, 33, 34, 35, 41, 186, reactant(s), 148, 150, 320, 321, 323
228, 233, 236, 264, 344, 379 reactions, 278
promoter, 91, 97, 102, 104, 109, 110, 112, 114, 115, reactive oxygen, 195, 265
118, 119, 274 reactive sites, 90
prophylactic, 169, 170, 201, 242 reactivity, 31, 54, 74, 89, 90, 92, 130, 177, 196, 248,
prophylaxis, 169, 201, 216, 290
proptosis, 179, 346, 347, 349 256, 265, 367
prostate gland, 44 reagents, 156
protease inhibitors, 236 recall, 90
proteasome, 69, 187 receptors, 69, 75, 87, 97, 100, 106, 146, 184, 185,
protection, 69, 174, 185
protective mechanisms, 91 186, 194, 313, 327
protein kinase C, 185 recognition, vii, x, 4, 10, 17, 28, 30, 49, 53, 65, 142,
proteinase, 46, 53, 76, 86, 94, 101, 115, 122, 142,
153, 154, 157, 158, 159, 165, 182, 191, 192, 193, 177, 188, 193, 209, 273, 328, 356
195, 196, 262, 273, 275, 276, 381 recommendations, 33, 82, 152, 168, 173, 174, 326,
proteins, 45, 74, 91, 97, 98, 184, 186, 265, 274, 314
proteinuria, 4, 25, 28, 104, 136, 147, 180, 216, 268, 332
301, 392, 393 reconstruction, 180, 249
pruritus, 29, 393 recovery, 7, 207, 212, 341
pseudocyst, 210 rectum, 278, 386
psoriasis, 105 recurrence, 131
psychosis, 46, 206 red blood cells, 24, 374, 377, 378
psychosomatic, 37 regeneration, 376
public health, 146 regions of the world, 66
pulmonary arteries, 137, 150, 241, 248, 249, 250, Registry, 26, 51, 57, 305, 309
257, 281 regression, 203
pulmonary edema, 241, 242, 246 rejection, 49, 245, 373, 394
pulmonary embolism, 242, 248, 250 relapses, 19, 43, 44, 46, 48, 62, 86, 158, 182, 207,
pulmonary function test, 244
pulmonary hypertension, 249, 250, 253, 256, 257 214, 216, 218, 275, 285, 289, 305, 323
P-value, 102, 103 relative size, 123
pyoderma gangrenosum, 382, 389 relatives, 96, 102, 114
pyrimidine, 324 relevance, vii, 46, 156
reliability, 326
relief, 348
remission, 24, 33, 43, 44, 46, 48, 49, 53, 61, 62, 63,

93, 131, 157, 159, 185, 186, 187, 193, 194, 196,
214, 238, 243, 244, 248, 261, 269, 270, 271, 275,
284, 289, 293, 305, 314, 323, 324, 334, 343, 347,
348, 351, 353, 393
renaissance, 24, 52

Complimentary Contributor Copy